Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects is a research paper published in Journal for ImmunoTherapy of Cancer (2023). On theSindex it has a DataRank of 0.385. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Owens Family Foundation
Grant: NA
National Cancer Institute
Grant: CA054174
National Cancer Institute
Grant: CA205965
National Cancer Institute
Grant: CA239390
Clayton Foundation
Grant: N/A
National Institutes of Health
Grant: AG021890
National Institutes of Health
Grant: GM113896
National Institutes of Health
Grant: TR002647
Dartmouth Cancer Center
Grant: Guyre Funds
National Cancer Institute
Grant: CA268641
NIA NIH HHS
Grant: T32 AG021890
NCATS NIH HHS
Grant: TL1 TR002647
MeSH Terms
Keywords